Cargando…

Changes in ovarian cancer survival during the 20 years before the era of targeted therapy

BACKGROUND: The survival of patients with ovarian cancer has improved because of surgery and chemotherapy. This study aimed to estimate the changes in survival rates among Korean women with ovarian cancer prior to the introduction of targeted therapy for ovarian cancer. METHODS: Data were obtained f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jung-Yun, Kim, Sunghoon, Kim, Young Tae, Lim, Myong Cheol, Lee, Boram, Jung, Kyu-Won, Kim, Jae Weon, Park, Sang-Yoon, Won, Young-Joo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975501/ https://www.ncbi.nlm.nih.gov/pubmed/29843633 http://dx.doi.org/10.1186/s12885-018-4498-z

Ejemplares similares

Prognosis of Cervical Cancer in the Era of Concurrent Chemoradiation from National Database in Korea: A Comparison between Squamous Cell Carcinoma and Adenocarcinoma
por: Lee, Jung-Yun, et al.
Publicado: (2015)

Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010
por: Lim, Myong Cheol, et al.
Publicado: (2013)

Role of systematic lymphadenectomy as part of primary debulking surgery for optimally cytoreduced advanced ovarian cancer: Reappraisal in the era of radical surgery
por: Eoh, Kyung Jin, et al.
Publicado: (2016)

Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999–2015
por: Lim, Myong Cheol, et al.
Publicado: (2018)

Trends in the Incidence and Survival Rates of Primary Ovarian Clear Cell Carcinoma Compared to Ovarian Serous Carcinoma in Korea
por: Kim, Se Ik, et al.
Publicado: (2022)

Phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer: primary analysis in the original cohort of KGOG3046/TRU-D
por: Park, Junsik, et al.
Publicado: (2023)

Characteristics of second primary breast cancer after ovarian cancer: a Korea central cancer registry retrospective study
por: Lee, Eun-Gyeong, et al.
Publicado: (2023)

Incidence and survival rates of primary uterine carcinosarcoma in Korea: a National Cancer Registry study
por: Kim, Se Ik, et al.
Publicado: (2022)

Second Primary Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancers after Breast Cancer Diagnosis: Korea Central Cancer Registry
por: Ha, Hyeong In, et al.
Publicado: (2021)

A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D
por: Lee, Jung-Yun, et al.
Publicado: (2019)

Comparative Effectiveness of Abdominal versus Laparoscopic Radical Hysterectomy for Cervical Cancer in the Postdissemination Era
por: Kim, Jin Hee, et al.
Publicado: (2019)

A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy
por: Eoh, Kyung Jin, et al.
Publicado: (2017)

Allogeneic Blood Transfusion Given Before Radiotherapy Is Associated with the Poor Clinical Outcome in Patients with Cervical Cancer
por: Lim, Myong Cheol, et al.
Publicado: (2008)

The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry
por: Ha, Hyeong In, et al.
Publicado: (2021)

Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer
por: Chung, Young Shin, et al.
Publicado: (2017)

Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012
por: Kim, Se Ik, et al.
Publicado: (2016)

Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer
por: Lee, Yong Jae, et al.
Publicado: (2020)

Impact of increased utilization of neoadjuvant chemotherapy on survival in patients with advanced ovarian cancer: experience from a comprehensive cancer center
por: Lee, Yong Jae, et al.
Publicado: (2018)

Correction of Funding information: The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999–2017: Korea Central Cancer Registry
por: Ha, Hyeong In, et al.
Publicado: (2022)

Comparing survival outcomes for cervical cancer based on the 2014 and 2018 International Federation of Gynecology and Obstetrics staging systems
por: Shin, Wonkyo, et al.
Publicado: (2021)

Dysregulated expression of homeobox family genes may influence survival outcomes of patients with epithelial ovarian cancer: analysis of data from The Cancer Genome Atlas
por: Eoh, Kyung Jin, et al.
Publicado: (2017)

Long-Term Survival Analysis of Intraperitoneal versus Intravenous Chemotherapy for Primary Ovarian Cancer and Comparison between Carboplatin- and Cisplatin-based Intraperitoneal Chemotherapy
por: Eoh, Kyung Jin, et al.
Publicado: (2017)

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2008
por: Jung, Kyu-Won, et al.
Publicado: (2011)

Survival outcomes and toxicity of intraoperative intraperitoneal chemotherapy in advanced epithelial ovarian cancer
por: Yoon, Ji-Young, et al.
Publicado: (2014)

Long Non-coding RNA HOXA11 Antisense Promotes Cell Proliferation and Invasion and Predicts Patient Prognosis in Serous Ovarian Cancer
por: Yim, Ga Won, et al.
Publicado: (2017)

Prognostic significance of supradiaphragmatic lymph node metastasis detected by (18)F-FDG PET/CT in advanced epithelial ovarian cancer
por: Lee, In Ok, et al.
Publicado: (2018)

Development and Validation of Ovarian Symptom Index-18 and Neurotoxicity-4 for Korean Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
por: Lee, Maria, et al.
Publicado: (2019)

Current Trends in the Incidence and Survival Rate of Urological Cancers in Korea
por: Joung, Jae Young, et al.
Publicado: (2017)

Can simple trachelectomy or conization show comparable survival rate compared with radical trachelectomy in IA1 cervical cancer patients with lymphovascular space invasion who wish to save fertility? A systematic review and guideline recommendation
por: Shim, Seung-Hyuk, et al.
Publicado: (2018)

Early Assessment of Response to Neoadjuvant Chemotherapy with (18)F-FDG-PET/CT in Patients with Advanced-Stage Ovarian Cancer
por: Chung, Young Shin, et al.
Publicado: (2020)

Position statements on genetic test for peritoneal, ovarian, and fallopian tubal cancers: Korean Society of Gynecologic Oncology (KSGO)
por: Choi, Min Chul, et al.
Publicado: (2016)

Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4
por: Kim, Yoo-Na, et al.
Publicado: (2023)

Survival impact of low anterior resection in patients with epithelial ovarian cancer grossly confined to the pelvic cavity: a Korean multicenter study
por: Kim, Miseon, et al.
Publicado: (2018)

Primary and recurrent ovarian high-grade serous carcinomas display similar microRNA expression patterns relative to those of normal ovarian tissue
por: Nam, Eun Ji, et al.
Publicado: (2016)

Pretreatment lymphocytopenia is an adverse prognostic biomarker in advanced‐stage ovarian cancer
por: Lee, Yong Jae, et al.
Publicado: (2019)

Impact of metformin on survival outcome in ovarian cancer: a nationwide population-based cohort study
por: Park, Jeong-Yeol, et al.
Publicado: (2021)

Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer
por: Lee, Yong Jae, et al.
Publicado: (2022)

Incidence trends for epithelial peritoneal, ovarian, and fallopian tube cancer during 1999–2016: a retrospective study based on the Korean National Cancer Incidence Database
por: Shin, Wonkyo, et al.
Publicado: (2020)

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015
por: Jung, Kyu-Won, et al.
Publicado: (2018)

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016
por: Jung, Kyu-Won, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_v98ed6rlkho1ndoeti7iqtd9g8